Merve Erkısa

865 total citations
37 papers, 687 citations indexed

About

Merve Erkısa is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Merve Erkısa has authored 37 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 14 papers in Molecular Biology and 10 papers in Organic Chemistry. Recurrent topics in Merve Erkısa's work include Metal complexes synthesis and properties (10 papers), Histone Deacetylase Inhibitors Research (5 papers) and Ferrocene Chemistry and Applications (5 papers). Merve Erkısa is often cited by papers focused on Metal complexes synthesis and properties (10 papers), Histone Deacetylase Inhibitors Research (5 papers) and Ferrocene Chemistry and Applications (5 papers). Merve Erkısa collaborates with scholars based in Türkiye, United States and Serbia. Merve Erkısa's co-authors include Engı̇n Ulukaya, Ferda Arı, Veysel T. Yılmaz, Ceyda İçsel, Muhíttín Aygün, Mehmet Çoşkun, Nazlıhan Aztopal, Saliha Şahin, Şeyma Aydınlık and Buse Cevatemre and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochimica et Biophysica Acta (BBA) - General Subjects and Dalton Transactions.

In The Last Decade

Merve Erkısa

33 papers receiving 681 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Merve Erkısa Türkiye 16 260 254 245 79 61 37 687
Bing-Jie Han China 17 343 1.3× 284 1.1× 415 1.7× 75 0.9× 27 0.4× 31 760
Buse Cevatemre Türkiye 18 312 1.2× 305 1.2× 445 1.8× 61 0.8× 47 0.8× 41 769
Aykut Özgür Türkiye 16 261 1.0× 374 1.5× 96 0.4× 120 1.5× 59 1.0× 42 807
Susana D. Lucas Portugal 18 273 1.1× 345 1.4× 107 0.4× 34 0.4× 114 1.9× 40 763
Yuxia Wang China 15 176 0.7× 349 1.4× 97 0.4× 67 0.8× 58 1.0× 49 671
David Vásquez Chile 15 232 0.9× 275 1.1× 169 0.7× 31 0.4× 45 0.7× 36 750
Cinzia Aiello Italy 16 376 1.4× 306 1.2× 190 0.8× 27 0.3× 35 0.6× 29 800
Didem Karakaş Türkiye 13 127 0.5× 329 1.3× 177 0.7× 30 0.4× 42 0.7× 30 617
Milena Salerno France 21 95 0.4× 400 1.6× 432 1.8× 104 1.3× 66 1.1× 37 898
Foram U. Vaidya India 15 160 0.6× 223 0.9× 168 0.7× 27 0.3× 29 0.5× 25 577

Countries citing papers authored by Merve Erkısa

Since Specialization
Citations

This map shows the geographic impact of Merve Erkısa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Merve Erkısa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Merve Erkısa more than expected).

Fields of papers citing papers by Merve Erkısa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Merve Erkısa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Merve Erkısa. The network helps show where Merve Erkısa may publish in the future.

Co-authorship network of co-authors of Merve Erkısa

This figure shows the co-authorship network connecting the top 25 collaborators of Merve Erkısa. A scholar is included among the top collaborators of Merve Erkısa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Merve Erkısa. Merve Erkısa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karakaş, Didem, Nazlıhan Aztopal, Merve Erkısa, et al.. (2025). Cancer-Stimulated Schwann Cells Exacerbate Pancreatic Cancer Aggressiveness via Exosomal Signaling. Pancreatology. 25(7). 1275–1275.
2.
İçsel, Ceyda, et al.. (2024). Pd(II) and Pt(II) saccharinate complexes with two phosphine derivatives: Synthesis, anticancer and antiangiogenic activities. Applied Organometallic Chemistry. 38(5). 6 indexed citations
3.
Uǧur, İlke, et al.. (2024). Human estrogen receptor alpha (ERα) targeted cyclic peptides inhibit cell growth and induce apoptosis in MCF-7 cells. SHILAP Revista de lepidopterología. 49(4). 542–550.
4.
Celikbas, Eda, Merve Erkısa, Abdullah Muti, et al.. (2022). Development of a cysteine responsive chlorinated hemicyanine for image-guided dual phototherapy. Bioorganic Chemistry. 122. 105725–105725. 10 indexed citations
5.
Erkısa, Merve, et al.. (2021). Natural Products as a Promising Therapeutic Strategy to TargetCancer Stem Cells. Current Medicinal Chemistry. 29(4). 741–783. 19 indexed citations
6.
Erkısa, Merve, Nazlıhan Aztopal, Elif Ertürk, et al.. (2020). Combination of Histone Deacetylase Inhibitor with Cu(II) 5,5-diethylbarbiturate Complex Induces Apoptosis in Breast Cancer Stem Cells: A Promising Novel Approach. Anti-Cancer Agents in Medicinal Chemistry. 21(14). 1850–1860. 2 indexed citations
7.
Erkısa, Merve, Şeyma Aydınlık, Buse Cevatemre, et al.. (2020). A promising therapeutic combination for metastatic prostate cancer: Chloroquine as autophagy inhibitor and palladium(II) barbiturate complex. Biochimie. 175. 159–172. 22 indexed citations
8.
Aydınlık, Şeyma, et al.. (2020). Synergistic interactions between resveratrol and doxorubicin inhibit angiogenesis both in vitro and in vivo. Polish Journal of Veterinary Sciences. 23(4). 571–580. 16 indexed citations
9.
Erkısa, Merve, et al.. (2020). Etoposide Loaded SPION‐PNIPAM Nanoparticles Improve the in vitro Therapeutic Outcome on Metastatic Prostate Cancer Cells via Enhanced Apoptosis. Chemistry & Biodiversity. 17(11). e2000607–e2000607. 7 indexed citations
10.
Erkısa, Merve, et al.. (2019). Mixed ligand complexes of Co(II), Ni(II) and Cu(II) with quercetin and diimine ligands: synthesis, characterization, anti-cancer and anti-oxidant activity. JBIC Journal of Biological Inorganic Chemistry. 25(1). 161–177. 48 indexed citations
11.
Erkısa, Merve, Didem Karakaş, & Engı̇n Ulukaya. (2019). Cancer Stem Cells: Root of the Evil. Critical Reviews™ in Oncogenesis. 24(1). 69–87. 12 indexed citations
13.
Cevatemre, Buse, Ceylan Hepokur, Merve Erkısa, et al.. (2018). An Investigation of Anticancer Effects of Doxorubicin and Calcitriol Combination on MCF-7 Cells. 41–46.
14.
Yılmaz, Veysel T., et al.. (2018). Synthesis, structures and anticancer potentials of platinum(II) saccharinate complexes of tertiary phosphines with phenyl and cyclohexyl groups targeting mitochondria and DNA. European Journal of Medicinal Chemistry. 155. 609–622. 65 indexed citations
15.
Yılmaz, Veysel T., Ceyda İçsel, Muhíttín Aygün, Merve Erkısa, & Engı̇n Ulukaya. (2018). Pd(II) and Pt(II) saccharinate complexes of bis(diphenylphosphino)propane/butane: Synthesis, structure, antiproliferative activity and mechanism of action. European Journal of Medicinal Chemistry. 158. 534–547. 27 indexed citations
16.
Disoma, Cyrollah, et al.. (2018). Usnea filipendula Induces Apoptosis in Human Colon Cancer Cell Lines. Indian Journal of Pharmaceutical Sciences. 80(6). 2 indexed citations
17.
Aztopal, Nazlıhan, et al.. (2017). Valproic acid, a histone deacetylase inhibitor, induces apoptosis in breast cancer stem cells. Chemico-Biological Interactions. 280. 51–58. 44 indexed citations
18.
Erkısa, Merve, et al.. (2017). Novel 1-(7-ethoxy-1-benzofuran-2-yl) substituted chalcone derivatives: Synthesis, characterization and anticancer activity. European Journal of Medicinal Chemistry. 136. 212–222. 90 indexed citations
19.
Cevatemre, Buse, Merve Erkısa, Nazlıhan Aztopal, et al.. (2017). A promising natural product, pristimerin, results in cytotoxicity against breast cancer stem cells in vitro and xenografts in vivo through apoptosis and an incomplete autopaghy in breast cancer. Pharmacological Research. 129. 500–514. 66 indexed citations
20.
Aydınlık, Şeyma, Merve Erkısa, Buse Cevatemre, et al.. (2016). Enhanced cytotoxic activity of doxorubicin through the inhibition of autophagy in triple negative breast cancer cell line. Biochimica et Biophysica Acta (BBA) - General Subjects. 1861(2). 49–57. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026